CUA: Chronic Scrotal Pain (2018): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
(4 intermediate revisions by the same user not shown) | |||
Line 20: | Line 20: | ||
== Anatomy == | == Anatomy == | ||
* See Testicle Anatomy Chapter Notes | * See [[Testicle|Testicle Anatomy Chapter Notes]] | ||
* '''Testicular innervation''' | * '''Testicular innervation''' | ||
** '''Sensory innervation of the scrotum and scrotal contents occurs via 2 somatic nerves:''' | ** '''Sensory innervation of the scrotum and scrotal contents occurs via 2 somatic nerves:''' | ||
Line 68: | Line 68: | ||
==== Mandatory ==== | ==== Mandatory ==== | ||
===== | ===== History and Physical Exam ===== | ||
* '''<span style="color:#ff0000">History''' | * '''<span style="color:#ff0000">History''' | ||
** Characterize pain (onset, location, quality, severity, referral, psychosocial impact, aggravating/alleviating factors) | ** Characterize pain (onset, location, quality, severity, referral, psychosocial impact, aggravating/alleviating factors) | ||
Line 77: | Line 77: | ||
** Prior evaluations/interventions for the presenting pain, as well as whether any prior treatment has brought relief | ** Prior evaluations/interventions for the presenting pain, as well as whether any prior treatment has brought relief | ||
** History of psychological, physical, or sexual abuse | ** History of psychological, physical, or sexual abuse | ||
*** | *** Males with a history of abuse are at increased risk of CP/CPPS | ||
* '''<span style="color:#ff0000">Physical exam (4)''' | * '''<span style="color:#ff0000">Physical exam (4)''' | ||
*# '''<span style="color:#ff0000">Scrotum''' | *# '''<span style="color:#ff0000">Scrotum''' | ||
Line 107: | Line 107: | ||
===== Other ===== | ===== Other ===== | ||
* '''Questionnaire''' | * '''Questionnaire''' | ||
** '''Chronic Epididymitis Symptom Index (CESI)''' | ** '''Chronic Epididymitis Symptom Index (CESI)''' | ||
***Measures the severity, frequency, and impact of chronic epididymitis; can serve as a useful tool for baseline evaluation, as well as follow-up | |||
* '''Spermatic cord block''' | * '''Spermatic cord block''' | ||
** '''Can serve be both diagnostic and therapeutic''' in patients with idiopathic CSP | ** '''Can serve be both diagnostic and therapeutic''' in patients with idiopathic CSP | ||
Line 121: | Line 122: | ||
* Natural history remains poorly studied | * Natural history remains poorly studied | ||
* See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994986/figure/f2-cuaj-6-161/ Figure 2] from Original Report | * See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994986/figure/f2-cuaj-6-161/ Figure 2] from Original Report | ||
* '''First-line (3):''' | * '''<span style="color:#ff0000">First-line (3):''' | ||
*# '''Lifestyle changes''' | *# '''<span style="color:#ff0000">Lifestyle changes''' | ||
*#* '''Modification of aggravating activities, scrotal support, and heat or cold therapies''' | *#* '''Modification of aggravating activities, scrotal support, and heat or cold therapies''' | ||
*# '''Physical therapy and acupuncture''' | *# '''<span style="color:#ff0000">Physical therapy and acupuncture''' | ||
*#* May improve CSP related to pelvic floor muscle dysfunction or referred pain from radiculopathies | *#* May improve CSP related to pelvic floor muscle dysfunction or referred pain from radiculopathies | ||
*# '''Psychological counselling''' | *# '''<span style="color:#ff0000">Psychological counselling''' | ||
*#* May help treat maladaptive self-harming behaviours, prevent catastrophic thinking, and potentially decrease pain-related physical limitations | *#* May help treat maladaptive self-harming behaviours, prevent catastrophic thinking, and potentially decrease pain-related physical limitations | ||
* '''Second-line (if conservative strategies fail)''' | * '''<span style="color:#ff0000">Second-line (if conservative strategies fail)''' | ||
** '''Medical management''' | ** '''<span style="color:#ff0000">Medical management''' | ||
*** See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994986/table/t2-cuaj-6-161/ Table 2] from Original Guideline | *** See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994986/table/t2-cuaj-6-161/ Table 2] from Original Guideline | ||
*** '''NSAIDs x 4 weeks''' | *** '''NSAIDs x 4 weeks''' | ||
Line 140: | Line 141: | ||
***Longer-term nerve blockade modalities are still considered experimental, but early results are promising | ***Longer-term nerve blockade modalities are still considered experimental, but early results are promising | ||
* '''Third line: surgical management''' | * '''<span style="color:#ff0000">Third line: surgical management''' | ||
** See Table 3 from Original Guideline | ** See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994986/table/t3-cuaj-6-161/ Table 3] from Original Guideline | ||
** '''The choice of initial surgical approach should be directed by the likely etiology of pain.''' | ** '''The choice of initial surgical approach should be directed by the likely etiology of pain.''' | ||
*# '''Vasectomy reversal in patients with post-vasectomy syndrome''' | *# '''Vasectomy reversal in patients with post-vasectomy syndrome''' |